Trials / Conditions / Resectable Lung Non-Small Cell Carcinoma

Resectable Lung Non-Small Cell Carcinoma

10 registered clinical trials studyying Resectable Lung Non-Small Cell Carcinoma — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	High-Dose Firmonertinib Plus Bevacizumab as Neoadjuvant Therapy for Resectable EGFRm Stage II-IIIB NSCLC NCT07182708	Peking University Cancer Hospital & Institute	Phase 2
Recruiting	Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and P NCT06431633	Fundación GECP	Phase 3
Recruiting	Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer NCT06008730	Emory University	Phase 2
Recruiting	Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell NCT06632327	Alliance for Clinical Trials in Oncology	Phase 3
Recruiting	A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectabl NCT06775275	The First Affiliated Hospital of Guangzhou Medical University	Phase 2
Recruiting	Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform NCT06349642	Mayo Clinic	—
Recruiting	Impact of Surgical Approach on Adaptation of Posture-respiratory Coupling NCT06276530	Assistance Publique - Hôpitaux de Paris	N/A
Recruiting	Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC NCT06241807	Shandong Cancer Hospital and Institute	Phase 2
Terminated	Bintrafusp Alfa Before Surgery for the Treatment of Untreated Resectable Non-small Cell Lung Cancer NCT04560686	M.D. Anderson Cancer Center	Phase 2
Completed	Prognostic Value of the 6-minute Stepper Test in Non-small Cell Lung Cancer Surgery NCT03824977	University Hospital, Rouen	—